Literature DB >> 12834800

Hippocampal serotonergic damage induced by MDMA (ecstasy): effects on spatial learning.

Jon E Sprague1, Amanda S Preston, Michael Leifheit, Brian Woodside.   

Abstract

3,4-Methylenedioxymethamphetamine (MDMA) use has been associated with a decline in various aspects of mnemonic function in humans. We therefore postulated that MDMA-induced damage of serotonergic nerve terminals would alter hippocampal processing. Seven days following treatment with MDMA (2 x 20 mg/kg sc, given 12 h apart), rat spatial learning and memory were tested utilizing the Morris water maze (MWM). No statistical differences were found in MWM platform acquisition latency or pathlength between controls and MDMA-treated animals. Probe trials revealed significantly higher proximity score averages and significantly reduced preference for the target quadrant in the MDMA-treated animals. MDMA treatment resulted in significant reduction (34%) in hippocampal serotonin (5-HT) levels 14 days after initial treatment. The findings of this study demonstrate that hippocampal serotonergic lesions induced by MDMA may be ostensibly linked to a reference memory deficit in rats tested with the MWM.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12834800     DOI: 10.1016/s0031-9384(03)00092-1

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  36 in total

1.  (±)3,4-methylenedioxymethamphetamine ("ecstasy") treatment modulates expression of neurotrophins and their receptors in multiple regions of adult rat brain.

Authors:  Ann M Hemmerle; Jonathan W Dickerson; Nicole R Herring; Tori L Schaefer; Charles V Vorhees; Michael T Williams; Kim B Seroogy
Journal:  J Comp Neurol       Date:  2012-08-01       Impact factor: 3.215

2.  Acute concomitant effects of MDMA binge dosing on extracellular 5-HT, locomotion and body temperature and the long-term effect on novel object discrimination in rats.

Authors:  Ratchanee Rodsiri; Clare Spicer; A Richard Green; Charles A Marsden; Kevin C F Fone
Journal:  Psychopharmacology (Berl)       Date:  2010-07-20       Impact factor: 4.530

3.  3,4-Methylenedioxymethamphetamine in adult rats produces deficits in path integration and spatial reference memory.

Authors:  Jessica A Able; Gary A Gudelsky; Charles V Vorhees; Michael T Williams
Journal:  Biol Psychiatry       Date:  2005-12-01       Impact factor: 13.382

4.  (+/-)-3,4-Methylenedioxymethamphetamine treatment in adult rats impairs path integration learning: a comparison of single vs once per week treatment for 5 weeks.

Authors:  Matthew R Skelton; Jessica A Able; Curtis E Grace; Nicole R Herring; Tori L Schaefer; Gary A Gudelsky; Charles V Vorhees; Michael T Williams
Journal:  Neuropharmacology       Date:  2008-07-12       Impact factor: 5.250

5.  Treadmill exercise alters ecstasy- induced long- term potentiation disruption in the hippocampus of male rats.

Authors:  Azam Sajadi; Iraj Amiri; Alireza Gharebaghi; Alireza Komaki; Masoumeh Asadbegi; Siamak Shahidi; Mehdi Mehdizadeh; Sara Soleimani Asl
Journal:  Metab Brain Dis       Date:  2017-06-13       Impact factor: 3.584

6.  MDMA-induced loss of parvalbumin interneurons within the dentate gyrus is mediated by 5HT2A and NMDA receptors.

Authors:  Stuart A Collins; Gary A Gudelsky; Bryan K Yamamoto
Journal:  Eur J Pharmacol       Date:  2015-04-30       Impact factor: 4.432

7.  Electroencephalographic and convulsive effects of binge doses of (+)-methamphetamine, 5-methoxydiisopropyltryptamine, and (±)-3,4-methylenedioxymethamphetamine in rats.

Authors:  Devon L Graham; Nicole R Herring; Tori L Schaefer; Katherine D Holland; Charles V Vorhees; Michael T Williams
Journal:  Open Neuropsychopharmacol J       Date:  2012

8.  Treatment with MDMA from P11-20 disrupts spatial learning and path integration learning in adolescent rats but only spatial learning in older rats.

Authors:  Matthew R Skelton; Michael T Williams; Charles V Vorhees
Journal:  Psychopharmacology (Berl)       Date:  2006-10-03       Impact factor: 4.530

9.  Attenuation of ecstasy-induced neurotoxicity by N-acetylcysteine.

Authors:  Sara Soleimani Asl; Bita Saifi; Abolhasan Sakhaie; Somayeh Zargooshnia; Mehdi Mehdizadeh
Journal:  Metab Brain Dis       Date:  2014-08-06       Impact factor: 3.584

10.  The role of adenosine receptor agonist and antagonist on Hippocampal MDMA detrimental effects; a structural and behavioral study.

Authors:  Fatemeh Kermanian; Mehdi Mehdizadeh; Mansureh Soleimani; Ali Reza Ebrahimzadeh Bideskan; Majid Asadi-Shekaari; Hamed Kheradmand; Hossein Haghir
Journal:  Metab Brain Dis       Date:  2012-09-09       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.